<DOC>
	<DOCNO>NCT02635087</DOCNO>
	<brief_summary>The investigator discover investigator ' miRNA tool useful tool predict patient stage II colon benefit chemotherapy.Then investigator plan make observation study may validation tool .</brief_summary>
	<brief_title>microRNAs Tool Stratifying Stage II Colon Cancer</brief_title>
	<detailed_description>This observation study . The investigator recruit patient agree use postoperative specimen miRNA tool examination receive investigator ' follow up.Their receiving chemotherapy decide doctor . The investigator see whether stratify tool could predict prognosis .</detailed_description>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<criteria>The informed consent obtain patient . With confirmed diagnosis stage II colon cancer . With moderate/good ECOG health rating ( PS ) : 01 score . The patient receive anticancer treatment primary surgery . The patient receive radical operation colon cancer negative margin . With severe comorbidities , cardiovascular disease , chronic obstructive pulmonary disease , diabetes mellitus , chronic renal dysfunction . With bad compliance contraindication enrollment . Pregnant woman lactate woman . With contraindication receive adjuvant chemotherapy .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>